COMP <GO>
EOSE vs MLAB // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Eos Energy Enterprises Inc. (Class A) (NASDAQ) VS. Mesa Laboratories Inc. (NASDAQ) • 15-METRIC TALLY: EOSE 1
— MLAB 9
■ METRIC PARITY
LAST: $1.98 (+1.54%) • MKT CAP: $721.1M
options-implied-move
—
LAST: $133.03 (+1.30%) • MKT CAP: $744.4M
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EOSE VS. MLAB)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EOSE | MLAB | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | -30.00% | 63.50% | -93.50 | MLAB | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 9.30% | -44.30 | MLAB | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 33.6x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 5.32% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | 7.40% | -67.40 | MLAB | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 2.70% | -62.70 | MLAB | /net-margins <GO> |
| Revenue Growth (YoY) | 180.00% | 3.40% | +176.60 | EOSE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.47% | -0.47 | MLAB | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 2.07 | -1.87 | MLAB | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 7/9 | -4.00 | MLAB | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 35.5 | 49.0 | -13.43 | MLAB | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 103.1x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $721.1M | $744.4M | -$23.4M | MLAB | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EOSE REV | MLAB REV | EOSE GROSS % | MLAB GROSS % | EOSE FCF | MLAB FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $114.2M | $249.1M | -50.0% | 63.5% | -$265.0M | $39.6M |
| FY 2024 | $15.6M | $241.0M | -50.0% | 62.6% | -$187.1M | $42.6M |
| FY 2023 | $16.4M | $216.2M | — | — | -$145.0M | $44.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EOSE // BETA —
MLAB // BETA —